GSK
740 hedge funds and large institutions have $11.7B invested in GSK in 2015 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 324 increasing their positions, 231 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
740
Holders Change
+12
Holders Change %
+1.65%
% of All Funds
19.74%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.24%
New
62
Increased
324
Reduced
231
Closed
41
Calls
$123M
Puts
$215M
Net Calls
-$91.6M
Net Calls Change
-$169M
Top Buyers
| 1 |
Barclays
London,
United Kingdom
|
+$231M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$56.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$52M |
| 4 |
SCCM
Schafer Cullen Capital Management
New York
|
+$50.9M |
| 5 |
SM
Seminole Management
New York
|
+$48.9M |
